A company marketing a brain health supplement has been advised by an industry watchdog to discontinue claims associated with protection against traumatic brain injuries and other health endpoints.
The Trump Administration’s attempt to prevent the use of the WeChat app within the United States has sent shock waves through that portion of the US dietary supplement industry involved with trade to and within China, an observer says.
Nutraveris, a software firm that consults on regulatory affairs for nutrition and dietary supplement markets in Europe, has announced that they have launched an online platform for supplement compliance in the United States.
The Federal Trade Commission has issued refunds in a case brought against an herbal based pain relief supplement that the Commission alleged had insufficient backing for its claims.
The Coronavirus pandemic was a wakeup call for many, highlighting how conventional medicine may not have immediate solutions. This is driving consumers to look for alternative solutions, but not everyone is convinced dietary supplements are the answer....
A ‘Regulatory Gap’ exists within the US dietary supplements industry, and recent talk of modernizing the regulations are ways to close that gap, FDA’s Steven Tave said yesterday
The recent upheavals in the United States around race relations has the nation questioning the insidious role prejudice has played in many walks of life. One group is seeking to use that rekindled awareness as added leverage to ensure equal opportunity...
Danish Researchers report that they have developed an ingestible capsule that captured bacteria and other biological samples while passing through the gastrointestinal tract of rats.
The US Food and Drug Administration rejected mid-August a New Dietary Ingredient notification from Phoenix Biotechnology Inc for oleandrin, a constituent of oleander touted as a COVID-19 cure.
A nonprofit group has asked FDA to crack down on the sale of tianeptine, an ingredient that is sold as an antidepressant drug in many markets outside of the United States.
The hemp/CBD industry may have gotten the cart before the horse in terms of extraction capacity and raw material supply, said an investment analyst familiar with the sector.
